Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Zander, Thomas; Moehler, Markus
Multimodal therapy of gastric cancerONKOLOGE. Bd. 26. H. 10. 2020 S. 912-917
Hofmann, Sarah; Goedeke, Jan; Koenig, Tatjana T. et al.
Multivariate analysis on complications of central venous access devices in children with cancer and severe disease influenced by catheter tip position and vessel insertion site (A STROBE-compliant study)SURGICAL ONCOLOGY-OXFORD. Bd. 34. 2020 S. 17-23
Rimassa, Lorenza; Woerns, Marcus-Alexander
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinomaLIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 1800-1811
Fontana, Elisa; Zichi, Clizia; Smyth, Elizabeth Catherine et al.
Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Koensgen, Dominique; Battista, Marco J.; Egger, Eva Katharina et al.
New therapeutic approaches in recurrent cervical cancerONKOLOGE. Bd. 26. H. 7. 2020 S. 623-629
Kaps, Leonard; Labenz, Christian; Galle, Peter R. et al.
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2020
Labenz, Christian; Huber, Yvonne; Michel, Maurice et al.
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionHEPATOLOGY COMMUNICATIONS. 2020
Zebralla, Veit; Mueller, Juliane; Wald, Theresa et al.
Obtaining Patient-Reported Outcomes Electronically With "OncoFunction" in Head and Neck Cancer Patients During AftercareFRONTIERS IN ONCOLOGY. Bd. 10. 2020
Bostel, T.; Mattke, M.; Nicolay, N. H. et al.
Oncological Long-term data on Carbon-based Radiotherapy of primary and recurrent sacral ChordomasSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. SUPPL 1. 2020 S. S60-S60
Rosentreter, J; Engl, A.-K.; Wojnowski, L et al.
Optimierung des Interaktionsmanagements zur Prävention potenzieller schwerwiegender Arzneimittelinteraktionen bei onkologischen Patientenbest practice onkologie. 2020 S. elektronisch